Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Clinical Neuropharmacology
|
January 1, 1986
Plasma neuroleptic concentration: in search of a therapeutic window
S Potkin, R Hahn, J Sramek
Psychiatry
|
January 1, 1996
New directions in the prevention and treatment of schizophrenia: a biological perspective
R J Wyatt, J A Apud, S Potkin
The American Journal of Psychiatry
|
October 1, 1979
An endogenous inhibitor of platelet MAO activity in chronic schizophrenia: failure to replicate
C D Wise, S Potkin, P Bridge, et al.
Journal of Neurochemistry
|
July 1, 1979
Mass fragmentography of phenylethylamine, m- and p-tyramine and related amines in plasma, cerebrospinal fluid, urine, and brain
F Karoum, H Nasrallah, S Potkin, et al.
Biological Psychiatry
|
February 1, 1984
Phenylacetic acid excretion in schizophrenia and depression: the origins of PAA in man
F Karoum, S Potkin, L W Chuang, et al.
Biological Psychiatry
|
October 1, 1980
Wheat gluten and haloperidol
D J Luchins, W J Freed, S Potkin, et al.
Journal of Child Neurology
|
January 1, 1991
Activating tasks for the study of visual-spatial attention in ADHD children: a cognitive anatomic approach
J M Swanson, M Posner, S Potkin, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
December 1, 1981
Quantitative determination of immunoglobulins in CSF and plasma of chronic schizophrenic patients
L E Delisi, D R Weinberger, S Potkin, et al.
Schizophrenia Research
|
November 1, 1989
Effect of attention on frontal distribution of delta activity and cerebral metabolic rate in schizophrenia
S M Guich, M S Buchsbaum, L Burgwald, et al.
Archives of General Psychiatry
|
January 13, 2000
Effects of temporal variability on p50 and the gating ratio in schizophrenia: a frequency domain adaptive filter single-trial analysis
J V Patterson, Y Jin, M Gierczak, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Clinical Neuropharmacology
|
January 1, 1986
Plasma neuroleptic concentration: in search of a therapeutic window
S Potkin, R Hahn, J Sramek
Psychiatry
|
January 1, 1996
New directions in the prevention and treatment of schizophrenia: a biological perspective
R J Wyatt, J A Apud, S Potkin
The American Journal of Psychiatry
|
October 1, 1979
An endogenous inhibitor of platelet MAO activity in chronic schizophrenia: failure to replicate
C D Wise, S Potkin, P Bridge, et al.
Journal of Neurochemistry
|
July 1, 1979
Mass fragmentography of phenylethylamine, m- and p-tyramine and related amines in plasma, cerebrospinal fluid, urine, and brain
F Karoum, H Nasrallah, S Potkin, et al.
Biological Psychiatry
|
February 1, 1984
Phenylacetic acid excretion in schizophrenia and depression: the origins of PAA in man
F Karoum, S Potkin, L W Chuang, et al.
Biological Psychiatry
|
October 1, 1980
Wheat gluten and haloperidol
D J Luchins, W J Freed, S Potkin, et al.
Journal of Child Neurology
|
January 1, 1991
Activating tasks for the study of visual-spatial attention in ADHD children: a cognitive anatomic approach
J M Swanson, M Posner, S Potkin, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
December 1, 1981
Quantitative determination of immunoglobulins in CSF and plasma of chronic schizophrenic patients
L E Delisi, D R Weinberger, S Potkin, et al.
Schizophrenia Research
|
November 1, 1989
Effect of attention on frontal distribution of delta activity and cerebral metabolic rate in schizophrenia
S M Guich, M S Buchsbaum, L Burgwald, et al.
Archives of General Psychiatry
|
January 13, 2000
Effects of temporal variability on p50 and the gating ratio in schizophrenia: a frequency domain adaptive filter single-trial analysis
J V Patterson, Y Jin, M Gierczak, et al.
Page
of 2